Investor Stock List
Ranked #2,110 of 8,699 institutional investors

Gilead Sciences, Inc.

Foster City, CA

$1.19B
US stock portfolio at live prices · today −$10.7M (−0.89%)
Market closed. Prices as of Nov 20, 6:11 AM ET
Value at quarter end (Q3 2026)
$1.46B
Change from Q2 2026
−$184.9M (−11.21%)
Positions
5 · 0 new, 0 sold out
Filed
Nov 6, 2026

Holdings

Q3 2026 13F, live prices
LKFT 46.9%RCUS 41.7%ASMB 9.42%KYTX 1.52%XLO 0.41%
StockSharesValue, live% of portfoliovs Q2 2026
LKFT Lakefront Biotherapeutics NV16,707,477$558M46.9%Unchanged
RCUS Arcus Biosciences, Inc.31,424,760$496M41.7%Unchanged
ASMB Assembly Biosciences, Inc.4,977,089$112M9.42%Unchanged
KYTX Kyverna Therapeutics, Inc.4,126,119$18.0M1.52%Unchanged
XLO Xilio Therapeutics, Inc.650,389$4.9M0.41%Unchanged